Tau phosphorylation in Alzheimer's disease: pathogen or protector?

Trends in Molecular Medicine - Tập 11 - Trang 164-169 - 2005
Hyoung-gon Lee1, George Perry1, Paula I. Moreira1,2, Matthew R. Garrett1, Quan Liu1, Xiongwei Zhu1, Atsushi Takeda3, Akihiko Nunomura4, Mark A. Smith1
1Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA
2Center for Neuroscience and Cell Biology of Coimbra, University of Coimbra, 3004-517 Coimbra, Portugal
3Department of Neurology, Tohoku University School of Medicine, Sendai, Miyagi 980-8574, Japan
4Department of Psychiatry and Neurology, Asahikawa Medical College, Asahikawa 078-8510, Japan

Tài liệu tham khảo

Trojanowski, 2000, Fatal attractions of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders, Ann N Y Acad Sci, 924, 62, 10.1111/j.1749-6632.2000.tb05561.x Fellous, 1977, Microtubule assembly in vitro. Purification of assembly-promoting factors, Eur. J. Biochem., 78, 167, 10.1111/j.1432-1033.1977.tb11726.x Weingarten, 1975, A protein factor essential for microtubule assembly, Proc. Natl. Acad. Sci. U. S. A., 72, 1858, 10.1073/pnas.72.5.1858 Arrasate, 2000, Tau dephosphorylation at tau-1 site correlates with its association to cell membrane, Neurochem. Res., 25, 43, 10.1023/A:1007583214722 Garcia de Ancos, 1993, Differences in microtubule binding and self-association abilities of bovine brain tau isoforms, J. Biol. Chem., 268, 7976, 10.1016/S0021-9258(18)53053-2 Cleveland, 1977, Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly, J. Mol. Biol., 116, 227, 10.1016/0022-2836(77)90214-5 Cleveland, 1977, Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin, J. Mol. Biol., 116, 207, 10.1016/0022-2836(77)90213-3 Kosik, 1989, Tau in situ hybridization in normal and Alzheimer brain: localization in the somatodendritic compartment, Ann. Neurol., 26, 352, 10.1002/ana.410260308 Kosik, 1989, Developmentally regulated expression of specific tau sequences, Neuron, 2, 1389, 10.1016/0896-6273(89)90077-9 Kosik, 1989, Along the way to a neurofibrillary tangle: a look at the structure of tau, Ann. Med., 21, 109, 10.3109/07853898909149195 Goedert, 1989, Amyloid plaques, neurofibrillary tangles and their relevance for the study of Alzheimer's disease, Neurobiol. Aging, 10, 405, 10.1016/0197-4580(89)90076-6 Himmler, 1989, Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains, Mol. Cell. Biol., 9, 1381, 10.1128/MCB.9.4.1381 Himmler, 1989, Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family, Mol. Cell. Biol., 9, 1389, 10.1128/MCB.9.4.1389 Lee, 1988, Identification of the major multiphosphorylation site in mammalian neurofilaments, Proc. Natl. Acad. Sci. U. S. A., 85, 1998, 10.1073/pnas.85.6.1998 Lee, 1988, Alzheimer disease tangles share immunological similarities with multiphosphorylation repeats in the two large neurofilament proteins, Proc. Natl. Acad. Sci. U. S. A., 85, 7384, 10.1073/pnas.85.19.7384 Andreadis, 1992, Structure and novel exons of the human tau gene, Biochemistry, 31, 10626, 10.1021/bi00158a027 Neve, 1986, Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2, Brain Res., 387, 271, 10.1016/0169-328X(86)90033-1 LaFerla, F.M. and Oddo, S. (2005) Alzheimer's disease: Aβ, tau and synaptic dysfunction. Trends Mol. Med. 11, in this issue Heutink, 2000, Untangling tau-related dementia, Hum. Mol. Genet., 9, 979, 10.1093/hmg/9.6.979 Georgieff, 1991, High molecular weight tau: preferential localization in the peripheral nervous system, J. Cell Sci., 100, 55, 10.1242/jcs.100.1.55 Brandt, 1993, Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro, J. Biol. Chem., 268, 3414, 10.1016/S0021-9258(18)53710-8 Bre, 1990, Effects of brain microtubule-associated proteins on microtubule dynamics and the nucleating activity of centrosomes, Cell Motil. Cytoskeleton, 15, 88, 10.1002/cm.970150205 Panda, 1995, Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau, Biochemistry, 34, 11117, 10.1021/bi00035a017 Harada, 1994, Altered microtubule organization in small-calibre axons of mice lacking tau protein, Nature, 369, 488, 10.1038/369488a0 Lindwall, 1984, Phosphorylation affects the ability of tau protein to promote microtubule assembly, J. Biol. Chem., 259, 5301, 10.1016/S0021-9258(17)42989-9 Kosik, 1990, Tau protein and neurodegeneration, Mol. Neurobiol., 4, 171, 10.1007/BF02780339 Kidd, 1964, Alzheimer's disease – an electron microscopical study, Brain, 87, 307, 10.1093/brain/87.2.307 Grundke-Iqbal, 1986, Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology, Proc. Natl. Acad. Sci. U. S. A., 83, 4913, 10.1073/pnas.83.13.4913 Grundke-Iqbal, 1986, Microtubule-associated protein tau. A component of Alzheimer paired helical filaments, J. Biol. Chem., 261, 6084, 10.1016/S0021-9258(17)38495-8 Bancher, 1989, Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease, Brain Res., 477, 90, 10.1016/0006-8993(89)91396-6 Braak, 1998, Evolution of neuronal changes in the course of Alzheimer's disease, J. Neural Transm. Suppl., 53, 127, 10.1007/978-3-7091-6467-9_11 Arriagada, 1992, Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease, Neurology, 42, 631, 10.1212/WNL.42.3.631 Hasegawa, 1998, Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly, FEBS Lett., 437, 207, 10.1016/S0014-5793(98)01217-4 Hong, 1998, Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17, Science, 282, 1914, 10.1126/science.282.5395.1914 Mori, 1987, Ubiquitin is a component of paired helical filaments in Alzheimer's disease, Science, 235, 1641, 10.1126/science.3029875 Yan, 1994, Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress, Proc. Natl. Acad. Sci. U. S. A., 91, 7787, 10.1073/pnas.91.16.7787 Ledesma, 1994, Analysis of microtubule-associated protein tau glycation in paired helical filaments, J. Biol. Chem., 269, 21614, 10.1016/S0021-9258(17)31849-5 Schweers, 1995, Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments, Proc. Natl. Acad. Sci. U. S. A., 92, 8463, 10.1073/pnas.92.18.8463 Alonso, 2001, Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein, J. Biol. Chem., 276, 37967, 10.1074/jbc.M105365200 Alonso, 1996, Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules, Nat. Med., 2, 783, 10.1038/nm0796-783 Salehi, 2003, Traffic at the intersection of neurotrophic factor signaling and neurodegeneration, Trends Neurosci., 26, 73, 10.1016/S0166-2236(02)00038-3 Ebneth, 1998, Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease, J. Cell Biol., 143, 777, 10.1083/jcb.143.3.777 Stamer, 2002, Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress, J. Cell Biol., 156, 1051, 10.1083/jcb.200108057 Spittaels, 1999, Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein, Am. J. Pathol., 155, 2153, 10.1016/S0002-9440(10)65533-2 Mattson, 1995, Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD, Neurobiol. Aging, 16, 447, 10.1016/0197-4580(94)00182-Z Ihara, 2001, PHF and PHF-like fibrils – cause or consequence?, Neurobiol. Aging, 22, 123, 10.1016/S0197-4580(00)00200-1 Morsch, 1999, Neurons may live for decades with neurofibrillary tangles, J. Neuropathol. Exp. Neurol., 58, 188, 10.1097/00005072-199902000-00008 Gomez-Isla, 1997, Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease, Ann. Neurol., 41, 17, 10.1002/ana.410410106 Kril, 2002, Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation, Acta Neuropathol. (Berl.), 103, 370, 10.1007/s00401-001-0477-5 Broe, 2001, Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies, Acta Neuropathol. (Berl.), 101, 616, 10.1007/s004010000337 Smith, 2002, Amyloid-β and tau serve antioxidant functions in the aging and Alzheimer brain, Free Radic. Biol. Med., 33, 1194, 10.1016/S0891-5849(02)01021-3 Nunomura, 2001, Oxidative damage is the earliest event in Alzheimer disease, J. Neuropathol. Exp. Neurol., 60, 759, 10.1093/jnen/60.8.759 Mulvihill, 1989, Immunoaffinity demonstration that paired helical filaments of Alzheimer disease share epitopes with neurofilaments, MAP2 and tau, Brain Res., 484, 150, 10.1016/0006-8993(89)90357-0 Wataya, 2002, High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal, J. Biol. Chem., 277, 4644, 10.1074/jbc.M110913200 Gomez-Ramos, 2003, Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells, J. Neurosci. Res., 71, 863, 10.1002/jnr.10525 Takeda, 2000, In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification, J. Neurochem., 75, 1234, 10.1046/j.1471-4159.2000.0751234.x Calingasan, 1999, Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease, J. Neurochem., 72, 751, 10.1046/j.1471-4159.1999.0720751.x Perez, 2000, Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal, FEBS Lett., 486, 270, 10.1016/S0014-5793(00)02323-1 Perez, 2002, Formation of aberrant phosphotau fibrillar polymers in neural cultured cells, Eur. J. Biochem., 269, 1484, 10.1046/j.1432-1033.2002.02794.x Zhu, 2000, Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease, J. Neuropathol. Exp. Neurol., 59, 880, 10.1093/jnen/59.10.880 Zhu, 2001, Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis, Mech. Ageing Dev., 123, 39, 10.1016/S0047-6374(01)00342-6 Zhu, 2001, Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease, J. Neurochem., 76, 435, 10.1046/j.1471-4159.2001.00046.x Reynolds, 2000, Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3β, J. Neurochem., 74, 1587, 10.1046/j.1471-4159.2000.0741587.x Miller, 2002, Axonal transport of neurofilaments in normal and disease states, Cell. Mol. Life Sci., 59, 323, 10.1007/s00018-002-8425-7 Zhu, 2003, Distribution, levels, and activation of MEK1 in Alzheimer's disease, J. Neurochem., 86, 136, 10.1046/j.1471-4159.2003.01820.x Zhu, 2004, Alzheimer's disease: the two-hit hypothesis, Lancet Neurol., 3, 219, 10.1016/S1474-4422(04)00707-0 Gerst, 1999, Role of oxidative stress in frontotemporal dementia, Dement. Geriatr. Cogn. Disord., 10, 85, 10.1159/000051220 Odetti, 2000, Lipoperoxidation is selectively involved in progressive supranuclear palsy, J. Neuropathol. Exp. Neurol., 59, 393, 10.1093/jnen/59.5.393 Ekinci, 2000, Phosphorylation of tau alters its association with the plasma membrane, Cell. Mol. Neurobiol., 20, 497, 10.1023/A:1007075115574 Arendt, 2003, Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals, J. Neurosci., 23, 6972, 10.1523/JNEUROSCI.23-18-06972.2003 Zhou, 2001, Hibernation, a model of neuroprotection, Am. J. Pathol., 158, 2145, 10.1016/S0002-9440(10)64686-X Takeda, 2000, Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau, J. Biol. Chem., 275, 5395, 10.1074/jbc.275.8.5395 Nunomura, 1999, RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease, J. Neurosci., 19, 1959, 10.1523/JNEUROSCI.19-06-01959.1999 Elder, 1998, Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content, J. Cell Biol., 141, 727, 10.1083/jcb.141.3.727 Rao, 1998, Neurofilament-dependent radial growth of motor axons and axonal organization of neurofilaments does not require the neurofilament heavy subunit (NF-H) or its phosphorylation, J. Cell Biol., 143, 171, 10.1083/jcb.143.1.171 Cash, 2003, Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation, Am. J. Pathol., 162, 1623, 10.1016/S0002-9440(10)64296-4 Liao, 1997, Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells, J. Biol. Chem., 272, 17565, 10.1074/jbc.272.28.17565 Stumptner, 2000, Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model, Am. J. Pathol., 156, 77, 10.1016/S0002-9440(10)64708-6 Steinert, 1988, Molecular and cellular biology of intermediate filaments, Annu. Rev. Biochem., 57, 593, 10.1146/annurev.bi.57.070188.003113 Fuchs, 1994, Intermediate filaments: structure, dynamics, function, and disease, Annu. Rev. Biochem., 63, 345, 10.1146/annurev.bi.63.070194.002021 Omary, 1998, Keratin modifications and solubility properties in epithelial cells and in vitro, Subcell. Biochem., 31, 105 Omary, 1997, Intermediate filament proteins of the liver: emerging disease association and functions, Hepatology, 25, 1043, 10.1002/hep.510250537 Arrasate, 2004, Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death, Nature, 431, 805, 10.1038/nature02998 Mandelkow, 2003, Clogging of axons by tau, inhibition of axonal transport and starvation of synapses, Neurobiol. Aging, 24, 1079, 10.1016/j.neurobiolaging.2003.04.007 Hutton, 1998, Association of missense and 5′-splice site mutations in tau with the inherited dementia FTDP-17, Nature, 393, 702, 10.1038/31508 Rissman, 2004, Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology, J. Clin. Invest., 114, 121, 10.1172/JCI200420640 Binder, 2005, Tau, tangles, and Alzheimer's disease, Biochim. Biophys. Acta, 1739, 216, 10.1016/j.bbadis.2004.08.014 Smith, 2005, Chronological primacy of oxidative stress in Alzheimer disease, Neurobiol. Aging, 26, 579, 10.1016/j.neurobiolaging.2004.09.021 Odetti, 1998, Early glycoxidation damage in brains from Down's syndrome, Biochim. Biophys. Res. Commun., 243, 849, 10.1006/bbrc.1998.8186 Nunomura, 2004, Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease, Neurobiol. Dis., 17, 108, 10.1016/j.nbd.2004.06.003